Pictet Alternative Advisors focuses on health with second thematic private equity strategy launch

Focused on biotech and healtcare

clock • 1 min read

Pictet Group’s wholly owned alternative investment business Pictet Alternative Advisors (PAA) has added to its thematic private equity franchise with the launch of a strategy focused on biotech and healthcare investments.

The new strategy aims to invest in biotech and healthcare-focused venture capital, growth and private equity funds globally and will make a "substantial" allocation to co-investments within five key segments in which it will make "high conviction" investments. Therapeutics, diagnostics, digital health, medical technology, and health care and services providers have been identified as the key segments for the strategy to invest in. Pierre Stadler, head of thematic private equity at PAA said: "From a private equity standpoint, the five areas provide opportunities across the full spectru...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Funds

Assets in the fund became "too few to keep the fund alive" following investors pulling their capital, however, the fund is still offered in separate accounts and LPs.

William Blair IM pulls UCITS China offering following 'key investor' withdrawals

'Assets too few to keep the fund alive'

clock 05 January 2024 • 1 min read
Of the firm's 124 equity categories, 19 returned a net negative performance in 2023, with the bottom ten dominated by Asia exposures.

Asian funds endure poor performance in 2023 as local currency bonds thrive

European fund performance review

Elliot Gulliver-Needham
clock 05 January 2024 • 2 min read
Royal London Short Money Market first took the top spot in October 2023, where it remains, while the £22.7bn Terry Smith fund has since been further overtaken by L&G Global Technology Index and Vanguard LifeStrategy 80% Equity.

Fundsmith Equity slips further down ii most bought list

Falls to fourth place

Elliot Gulliver-Needham
clock 04 January 2024 • 2 min read
Trustpilot